Corneal transplantation (or keratoplasty) is a surgical procedure that replaces a damaged or diseased cornea with healthy donor tissue. It is one of the most successful transplants in medicine, with high success rates when the patient is properly selected and postoperative care is followed.
The transplant is performed when the cornea loses its transparency, shape, or functionality. The most common causes include:
Post-infectious scarring (from herpes, bacterial ulcers, or fungi).
Ocular trauma (chemical burns, penetrating wounds).
Corneal edema (endothelial failure, as in Fuchs' dystrophy).
Advanced keratoconus (when intracorneal rings or cross-linking are insufficient).
Pellucid marginal degeneration.
Congenital diseases (hereditary corneal dystrophies).
Rejection of a previous transplant.
Symptoms: Redness, pain, blurred vision, and photophobia.
Previous corneal vascularization.
History of rejection.
Inappropriate use of immunosuppressants.
Infection (bacterial or fungal keratitis).
Glaucoma (due to postoperative increased intraocular pressure).
Irregular astigmatism (requiring special lenses or additional surgery).
Primary graft failure (in DMEK, if it does not adhere well).
Corneal trauma sutured with 10-0 nylon. Corneal transplant likely required.
Topical corticosteroids (prednisolone) to prevent rejection (sometimes for 1–2 years).
Antibiotics (to prevent infection).
Immunosuppressants (in high-risk cases)
Protective eyewear against knocks or friction.
Avoid swimming or dusty environments for 3–6 months.
First week: Monitor graft adherence.
First month: Assess for early signs of rejection.
Every 6–12 months: Long-term monitoring.
Do not rub your eyes.
Use artificial tears if dryness is present.
Control systemic diseases (diabetes, hypertension).
PKP: 5-year graft survival: 70–90% (depending on the cause).
DMEK/DSAEK: 90–95% success rate in the first year.
Keratoprosthesis: Last option, with a high risk of complications.
5-year graft survival: 70–90% (depending on the cause).
90–95% success rate in the first year.
Last option, with a high risk of complications.
Replacement of the entire cornea.
Replacement of the anterior layers (preserves the patient's endothelium).
Replacement of the endothelium only (for corneal edema).
Artificial corneal implant (in cases of multiple rejection or complex diseases).
The longevity and success of a corneal transplant depend largely on the quality of the donated tissue, as not all corneas are equally viable. Eye banks evaluate multiple factors to ensure a safe and effective graft.
Optimal: Donors between 18 and 65 years of age.
Corneas from younger donors (≤40 years):
Higher endothelial cell density (essential for corneal transparency).
Lower risk of premature degeneration.
Corneas from older donors (≥70 years):
Possible lower endothelial cell count.
Higher risk of progressive opacity.
Minimum requirement: 2,000–2,500 cells/mm² (a healthy cornea has ~2,500–3,000).
Evaluation: Pre-transplant specular microscopy.
Low endothelial cells (<2,000/mm²) → Higher risk of post-transplant endothelial failure.
Safe limit: 7–14 days in a preservation medium (such as Optisol-GS liquid).
More than 14 days: Risk of edema and cell death.
Ideal: Sudden death (e.g., trauma, heart attack).
Should be avoided:
Infectious diseases (HIV, hepatitis B/C, syphilis, active COVID-19).
Neurodegenerative diseases (Creutzfeldt-Jakob disease).
Metastatic cancer (theoretical risk of transmission).
Previous surgeries (e.g., LASIK, cataracts).
Corneal diseases (keratoconus, dystrophies).
Ocular trauma.
Extraction: Within 12–24 hours postmortem.
Eye bank evaluation:
Specular microscopy (endothelial count).
Viability tests (turgor, transparency).
Microbiological tests (to rule out infections).
Preservation: In specialized media at 4°C (e.g., Optisol-GS).
Good tissue:
Faster recovery.
Lower risk of rejection or primary failure.
Increased likelihood of corneal edema.
Possible need for retransplantation.
10-0 Nylon Suture
10-0 nylon sutures are one of the finest materials used in ophthalmic surgery, essential for high-precision procedures such as corneal transplants, complex cataract surgery, or ocular trauma repair. Their thinness and strength make them indispensable in microsurgery.
Diameter: 20–30 microns (µm).
Human hair: 70–100 µm.
Red blood cell: 7–8 µm.
Needle length: 5–8 mm (almost invisible to the naked eye).
Material: Non-absorbable monofilament nylon (polyether).
Strength: Supports delicate tissues without breaking.
Minimizes inflammation: Less tissue reaction vs. silk sutures.
Corneal transplantation (penetrating keratoplasty).
Repair of iris or corneal wounds.
Fixation of intraocular lenses (for dislocations).
Suturing of phacoemulsification incisions (cataract surgery).
Sutures in pterygium (carnosity) surgery
Requires surgical loupes or a microscope.
Needles are so fine they can bend easily.
Knots must be small and secure to avoid irritation.
In corneal transplants, they are removed between 12 and 18 months.
In cataract surgery, one week after surgery.
In cataract surgery, one week after surgery.
In pterygium (carnosity) surgery, 2-3 weeks after surgery.
Corneal transplantation (keratoplasty) is a safe and effective procedure, but not all patients are immediate candidates. The decision depends on ocular, systemic, and surgical risk factors. Here are the key conditions that may limit or delay surgery:
Severe glaucoma: High intraocular pressure damages the optic nerve and compromises the success of the transplant.
Advanced retinopathy (e.g., diabetic or retinal detachment): If the retina is nonfunctional, the transplant will not improve vision.
Extreme dry eye: Risk of postoperative ulcers or infections.
Recurrent ocular herpes: Must be inactive for ≥6 months.
Uncontrolled uveitis: Increases the risk of rejection.
Corneas with poor endothelial quality (<2,000 cells/mm²).
Recipients with severe corneal vascularization: Higher risk of rejection.
Uncontrolled autoimmune diseases (lupus, rheumatoid arthritis).
Decompensated diabetes: Delays healing.
Pregnancy: Postponed until after delivery (except in emergencies).
If the patient expects "perfect vision" but has other eye diseases (e.g., macular degeneration), the transplant may not meet their expectations.
Specialized contact lenses (for keratoconus or corneal edema).
Keratoprosthesis (artificial cornea): In cases of multiple rejection or complex diseases.
Medical Treatments: For corneal edema (hypertonic solutions).
Transplant success rates exceed 90% in well-selected patients, but preventing rejection requires steroid drops for months or years.
Content Warning
Sensitive Content
Not Recommended for Children
Advanced Keratoconus Before Corneal Transplant
Advanced Keratoconus After Corneal Transplant
Corneal Perforation Before Corneal Transplant
Corneal Perforation after Corneal Transplant
Scarred and Vascularized Cornea Before Corneal Transplant
Scarred and Vascularized Cornea after Corneal Transplant
Infection and impending corneal perforation before corneal transplantation
Infection and impending corneal perforation after corneal transplant
Corneal Infection Before Corneal Transplant
Corneal Infection after Corneal Transplant
Old Corneal Trauma before Corneal Transplant
Old Corneal Trauma after Corneal Transplant
Corneal Scar Before Corneal Transplant
Corneal Scar after Corneal Transplant
Graft failure, fibrosis and vascularization before corneal transplantation
Graft failure, fibrosis, and vascularization after corneal transplantation
Corneal Failure Before Corneal Retransplantation
Corneal Failure after Corneal Retransplantation
Graft Failure and Cataracts Before Corneal Transplantation
Graft Failure and Cataracts after Corneal Transplantation